Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. (Q52607333)

3 July 2018

title

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. (English)

1 reference

3 July 2018

main subject

machine learning

0 references

The Cancer Genome Atlas

1 reference

14

1 reference

http://europepmc.org/abstract/MED/29617658

4 May 2018

Giovanni Ciriello

Giovanni Ciriello

Cancer Genome Atlas Research Network

10

0 references

12

Cancer Genome Atlas Research Network

1 reference

PMCID

5918694

3 July 2018

Francisco Sánchez-Vega

Francisco Sanchez-Vega

2

0 references

Nikolaus Schultz

11

Nikolaus Schultz

1 reference

3 July 2018

0 references

7

Chris Sander

1 reference

3 July 2018

Andrew D Cherniack

8

Andrew D Cherniack

1 reference

3 July 2018

Konnor C. La

3

Konnor La

1 reference

3 July 2018

author name string

Gregory P Way

1

1 reference

3 July 2018

Joshua Armenia

4

1 reference

3 July 2018

Walid K Chatila

5

1 reference

3 July 2018

Augustin Luna

6

1 reference

3 July 2018

Marco Mina

9

1 reference

3 July 2018

Yolanda Sanchez

13

1 reference

3 July 2018

language of work or name

English

0 references

publication date

1 April 2018

1 reference

3 July 2018

published in

Cell Reports

1 reference

3 July 2018

volume

23

1 reference

3 July 2018

issue

1

1 reference

3 July 2018

page(s)

172-180.e3

1 reference

3 July 2018

describes a project that uses

ggplot2

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=5918694

ggplot2

2 references

10 June 2022

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

limma

limma

2 references

22 June 2022

https://europepmc.org/article/PMC/5918694

based on heuristic

inferred from PubMed Central ID database lookup

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

dplyr

dplyr

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

PathwayMapper: a collaborative visual web editor for cancer pathways and genomic data

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

COSMIC: somatic cancer genetics at high-resolution

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Pathway-Based Genomics Prediction using Generalized Elastic Net

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Precision oncology: origins, optimism, and potential

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

limma powers differential expression analyses for RNA-sequencing and microarray studies

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

The developing story of Sprouty and cancer

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Dragging ras back in the ring

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

The Cancer Genome Atlas Pan-Cancer analysis project

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Mutational heterogeneity in cancer and the search for new cancer-associated genes

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Roles for KRAS in pancreatic tumor development and progression

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Mutations of the BRAF gene in human cancer

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

ras GTPase activating protein: signal transmitter and signal terminator

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

The neurofibromatosis type 1 gene encodes a protein related to GAP

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Oncogenic Signaling Pathways in The Cancer Genome Atlas.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Precision oncology in the age of integrative genomics.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

Cancer transcriptome profiling at the juncture of clinical translation.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918694

OncoKB: A Precision Oncology Knowledge Base

13 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29617658

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regularization and variable selection via the elastic net

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2018.03.046

Data Structures for Statistical Computing in Python

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2018.03.046

Identifiers

DOI

10.1016/J.CELREP.2018.03.046

1 reference

3 July 2018

PMCID

5918694

1 reference

3 July 2018

PubMed ID

29617658

1 reference

3 July 2018